Treatment experiences of Wilm's tumor with vena cava thrombus

Weijing He,Gongbao Liu,Kuiran Dong
DOI: https://doi.org/10.3969/j.issn.1671-6353.2017.05.003
2017-01-01
Abstract:Objective To explore the treatment and prognosis of Wilm's tumors with vena cava thrombus. Methods The clinical data were reviewed and analyzed for 12 patients of Wilm's tumors with vena cava thrombus and received systemic therapy from 2010 to 2016. Results There are 4 boys and 8 girls with an average diagnostic age of 3. 94 (1. 5-7) years. The involved side was left (n=5) and right (n=7). And the stages wereⅡ(n=5),Ⅲ(n=4) andⅣ(n=3). The thrombus level wasⅠ(n=5),Ⅱ(n=2),Ⅲ(n=2) andⅣ(n=3). Five level I and 1 level II patients underwent immediate surgery for total thrombus resection. Another 6 patients received preoperative neoadjuvant chemotherapy and 5 of them had residual thrombus. All patients recovered well postoperatively and pathology confirmed Wilm's tumor. Tumor cells were absent in thrombus of patients on neoadjuvant chemotherapy. All patients completed complete chemoradiotherapy. There was no recurrence during a follow-up period of 0. 5~6 years. The residual thrombus of 5 patients showed no obvious change. Conclusion Neoadjuvant chemotherapy is required for patients with vena cava thrombus. Minimal residual of thrombus is accpetable. Systemic chemotherapy and radiotherapy after surgery is essential for achieving an excellent prognosis for Wilm's tumor with vena cava thrombus.
What problem does this paper attempt to address?